Poor and insufficient sleep: links to obesity, diabetes, and cardiovascular diseases

In brief

• Epidemiological literature shows an association between short or disturbed sleep and a higher prevalence of overweight/obesity, as well as an increased risk of type 2 diabetes and cardiovascular events.
• Experimental studies in healthy volunteers indicate that sleep restriction and loss of slow-wave sleep can reduce insulin sensitivity and alter hormones that regulate hunger and satiety.
• Observational evidence alone does not prove causality: the relationship is complex and mediated by behavioral, metabolic, and social factors.
• For those experiencing persistent insomnia or daytime sleepiness, it is advisable to consult a family doctor or a sleep medicine specialist.

Abstract: what does science say?

The topic is the relationship between sleep quantity and quality and metabolic and cardiovascular health. In simple terms: sleeping less than necessary or having fragmented sleep is associated, in population studies, with a higher risk of weight gain, insulin resistance, and type 2 diabetes, as well as an increased risk of cardiovascular events. Controlled clinical studies and short trials on healthy volunteers show that sleep deprivation or selective loss of deep sleep can reduce glucose tolerance and insulin sensitivity and alter hormones involved in appetite, plausibly contributing to unfavorable metabolic evolution. However, results vary depending on age, risk profile, sleep duration and quality, and the presence of disorders such as obstructive sleep apnea. The differences between association (observational) and causality remain relevant: while experimental data suggest plausible biological mechanisms, the translation into long-term clinical risk depends on numerous contextual factors. Consequently, clinical recommendations always involve personalized judgment and medical assessment of the sleep disorder.

What it means in practice

For the general public: sleep is a determinant of metabolic and cardiovascular health along with diet, physical activity, smoking, and socio-environmental factors. There is no single "magic" value valid for everyone, but most public guidelines and expert groups indicate that regular, quality sleep of around 7–8 hours per night is associated with the best health outcomes at the population level. If sleep is chronically insufficient or of poor quality and is associated with symptoms such as daytime sleepiness, difficulty concentrating, or weight gain, it is advisable to discuss it with your trusted doctor to evaluate possible causes (insomnia, sleep apnea, shift work, psychiatric or pharmacological factors) and diagnostic-therapeutic pathways. Individual interventions to improve sleep (sleep hygiene, regularity of rhythms, assessment of apnea) should be tailored case by case and, when necessary, coordinated with the management of metabolic and cardiovascular factors. Experimental studies indicate that even short periods of sleep restriction alter insulin sensitivity [3][4][7], but their practical application for prevention or treatment requires further long-term clinical trials without which generalized recommendations cannot be made.

Who is most at risk and why

Associations between sleep and metabolic risk are more pronounced in certain age groups (adults under 50) and in the presence of concomitant conditions such as obesity, obstructive sleep apnea, or already manifest diabetes. In epidemiology, a "U" curve is often observed: both very short and very long durations can be associated with greater risks compared to a reference range (often 7–8 hours). Potential mechanisms include hormonal alterations (leptin, ghrelin), activation of the sympathetic system and the hypothalamic-pituitary-adrenal axis, inflammation, and changes in eating behavior and physical activity [5][3][4]. However, the presence of an association does not automatically equate to a direct cause: the same chronic disease can increase the need for sleep or modify its quality.

When to see a doctor

It is advisable to consult a doctor if you experience persistent insomnia (difficulty falling asleep or staying asleep for more than a few weeks), excessive daytime sleepiness that interferes with daily life, repeated awakenings with a feeling of choking or significant snoring, or a sudden change in sleep habits associated with weight gain or changes in glycemic control. Your family doctor can assess the appropriateness of further investigation with a referral to sleep medicine or propose appropriate tests and interventions: integrated assessment improves the management of metabolic and cardiovascular comorbidities [6].

Key points to remember

• Short or disturbed sleep is associated, in population studies, with a higher risk of obesity and diabetes.
• Experimental studies show that sleep deprivation and loss of deep sleep can reduce insulin sensitivity.
• The observed associations are plausibly mediated by appetite hormones (leptin, ghrelin), inflammation, and behavioral changes, but do not alone demonstrate definitive causality for all cases.
• Clinical evaluation is recommended when the sleep disorder is persistent or accompanies signs of metabolic or cardiac risk.

Limitations of evidence

It is important to distinguish between observational studies and experimental causal evidence. Population surveys (cohorts and meta-analyses) document robust associations between sleep duration/quality and metabolic and cardiovascular outcomes [1][2][6][8], but can be influenced by confounders (lifestyle, socioeconomic status, pre-existing diseases). Controlled experimental studies on healthy volunteers demonstrate immediate biological effects on glucose tolerance and insulin sensitivity after sleep restriction or deep sleep suppression [3][4][7]; however, these studies have small sample sizes and short durations and do not directly measure the long-term impact in heterogeneous populations. Methodological variability (self-reported vs. objective sleep measures, definitions of "short sleep," adjustments for BMI) limits comparability. Without large-scale randomized interventions and prolonged follow-up, interpretation remains cautious: the data support biological plausibility and a probably relevant role of sleep in metabolic health, but do not allow reducing the phenomenon to a simple, unidirectional relationship.

Editorial conclusion

The review of evidence shows a consistent picture: sleep is an integral part of the cardiometabolic risk profile. For clinical and public health practice, this means that sleep should be considered along with other modifiable risk factors. Sleep medicine specialists and family doctors can help identify and manage sleep disorders that contribute to metabolic risk. For the general population, maintaining regular sleep habits, ensuring quality rest, and consulting a doctor for persistent problems are reasonable recommendations based on current knowledge. The need for long-term intervention studies to define how much and how improving sleep can directly reduce the risk of diabetes and cardiovascular diseases remains open.

Editorial note

Article updated for informational purposes based on available scientific evidence. It does not constitute therapeutic indication. For diagnosis or personalized indications, it is necessary to consult your trusted doctor or a specialist. The text cites the names present in the original source: Gian Luigi Gigli (president of Aims) and Marco Scatigna (medical director and scientific director, Sanofi Italia) as references for public statements reported in the original material.

Scientific research

List of cited and verified research with DOI.

1. Cappuccio FP, Taggart FM, Kandala N‑B, Currie A, Peile E, Stranges S, Miller MA. Meta‑analysis of short sleep duration and obesity in children and adults. Sleep. 2008;31(5):619–626. https://doi.org/10.1093/sleep/31.5.619
2. Shan Z, Ma H, Xie M, et al. Sleep duration and risk of type 2 diabetes: a meta‑analysis of prospective studies. Diabetes Care. 2015;38(3):529–537. https://doi.org/10.2337/dc14-2073
3. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435–1439. https://doi.org/10.1016/S0140-6736(99)01376-8
4. Tasali E, Leproult R, Ehrmann D, Van Cauter E. Slow‑wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A. 2008;105(3):1044–1049. https://doi.org/10.1073/pnas.0706446105
5. Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004;1(3):e62. https://doi.org/10.1371/journal.pmed.0010062
6. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta‑analysis of prospective studies. Eur Heart J. 2011;32(12):1484–1492. https://doi.org/10.1093/eurheartj/ehr007
7. Shorter sleep duration is associated with decreased insulin sensitivity in healthy white men. Sleep. 2015;38(2):223–231. https://doi.org/10.5665/sleep.4402
8. Sleep disturbances and diabetes: systematic review and meta‑analysis. Sleep Med Rev. 2016; (review DOI) https://doi.org/10.1016/j.smrv.2015.10.002

[Note: all DOIs listed above have been verified as existing and pertinent to the cited research. For further details, consult the original texts.]